Case Report: Failure of Subcutaneous Ivermectin in Treating Strongyloides Hyperinfection

被引:18
作者
Leung, Victor
Al-Rawahi, Ghada N.
Grant, Jennifer
Fleckenstein, Lawrence
Bowie, William
机构
[1] Univ British Columbia, Dept Internal Med, Vancouver, BC V5Z 1M9, Canada
[2] Childrens & Womens Hlth Ctr British Columbia, Dept Pathol & Lab Med, Vancouver, BC, Canada
[3] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC V5Z 1M9, Canada
[4] Vancouver Gen Hosp, Div Med Microbiol & Infect Control, Vancouver, BC, Canada
[5] Univ Iowa, Coll Pharm, Div Clin & Adm Pharm, Iowa City, IA 52242 USA
[6] Univ British Columbia, Div Infect Dis, Vancouver, BC V5Z 1M9, Canada
关键词
D O I
10.4269/ajtmh.2008.79.853
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
A man with Escherichia coli meningitis and bacteremia, while on dexamethasone, developed Strongyloides hyperinfection syndrome and died despite salvage therapy with Subcutaneous ivermectin. We report the first documented total and free levels of subcutaneous ivermectin used for therapy.
引用
收藏
页码:853 / 855
页数:3
相关论文
共 22 条
[1]   The comparative serum disposition kinetics of subcutaneous administration of doramectin, ivermectin and moxidectin in the Australian Merino sheep [J].
Barber, S ;
Bowles, V ;
Lespine, A ;
Alvinerie, M .
JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS, 2003, 26 (05) :343-348
[2]   TREATMENT OF STRONGYLOIDES-STERCORALIS HYPERINFECTION SYNDROME WITH THIABENDAZOLE ADMINISTERED PER RECTUM [J].
BOKEN, DJ ;
LEONI, PA ;
PREHEIM, LC .
CLINICAL INFECTIOUS DISEASES, 1993, 16 (01) :123-126
[3]   Parenteral ivermectin in Strongyloides hyperinfection [J].
Chiodini, PL ;
Reid, AJC ;
Wiselka, MJ ;
Firmin, R ;
Foweraker, J .
LANCET, 2000, 355 (9197) :43-44
[4]   SEROEPIDEMIOLOGY OF STRONGYLOIDES INFECTION IN THE SOUTHEAST-ASIAN REFUGEE POPULATION IN CANADA [J].
GYORKOS, TW ;
GENTA, RM ;
VIENS, P ;
MACLEAN, JD .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1990, 132 (02) :257-264
[5]   Fatal outcome of a hyperinfection syndrome despite successful eradication of Strongyloides with subcutaneous ivermectin [J].
Haubner, HP ;
Galle, J ;
Chiodini, PL ;
Rupp, J ;
Birke, R ;
Vollmer, E ;
Zabel, P ;
Lange, C .
INFECTION, 2005, 33 (5-6) :383-386
[6]   Strongyloides stercoralis in the immunocompromised population [J].
Keiser, PB ;
Nutman, TB .
CLINICAL MICROBIOLOGY REVIEWS, 2004, 17 (01) :208-+
[7]   A CASE OF SEVERE STRONGYLOIDES-STERCORALIS INFECTION WITH JEJUNAL PERFORATION IN AN AUSTRALIAN EX-PRISONER-OF-WAR [J].
KENNEDY, S ;
CAMPBELL, RM ;
LAWRENCE, JE ;
NICHOL, GM ;
RAO, DM .
MEDICAL JOURNAL OF AUSTRALIA, 1989, 150 (02) :92-93
[8]   Liquid chromatographic assay of ivermectin in human plasma for application to clinical pharmacokinetic studies [J].
Kitzman, D ;
Wei, SY ;
Fleckenstein, L .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2006, 40 (04) :1013-1020
[9]   IVERMECTIN BINDS AVIDLY TO PLASMA-PROTEINS [J].
KLOTZ, U ;
OGBUOKIRI, JE ;
OKONKWO, PO .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1990, 39 (06) :607-608
[10]   An in vitro larval motility assay to determine anthelmintic sensitivity for human hookworm and Strongyloides species [J].
Kotze, AC ;
Clifford, S ;
O'Grady, J ;
Behnke, JM ;
McCarthy, JS .
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2004, 71 (05) :608-616